Gyrolab is a bioanalytical, automated system that addresses critical needs within the development of therapeutic proteins, from early screening of drug candidates to the completion of clinical trials.

Gyrolab miniaturizes and integrates assay steps for protein quantification immunoassays, which significantly boosts efficiency and productivity, as well as providing additional, unique advantages.
Gyrolab is an open technology platform that is compatible with any immunoassay design.

Gyrolab comprises an automated instrument that processes CD (compact disc) microlaboratories, along with intuitive software.

Miniaturized assay format uses nanoliter volumes minimizing the consumption of precious samples and reagents. The extremely small sample volumes makes multiplexing superfluous, Gyrolab combines the robustness of singleplexing with the flexibility of multiplexing.

Gyrolab has a very broad dynamic range, up to four orders of magnitude, without matrix or hook effects. This reduces sample repeat rates, avoids the need for tedious dilutions and reduces potential errors. The dynamic range is further extended through the choice of CDs.

Flow-through format shortens analysis time and reduces sample matrix effects. Results are generated in less than one hour-112 samples. Hundreds of samples are processed in parallel under uniform conditions providing increased throughput.

An open, flexible technology platform with unique assay development tools mean that new assays can be developed and optimized within days rather than weeks. Existing ELISA assays are easily transferred.

Excellent scalability for meeting the increasing number of analyses required. Assay transfer within or between sites for example CROs/CMOs is a seamless, rapid and highly efficient process, unsurpassed in this industry.

Gyrolab xP complies with the requirements of 21 CFR part 11 and is accompanied by comprehensive computer system validation support.